TNIB Investment Highlights

New Post Public Reply Private Reply Replies (0) Message Board

Sep 14, 2012 at 9:37 AM

[b]TNIB >> Investment Highlights[/b]

HTTP://WWW.SHAKERZANDMOVERZ.COM

Chart forming a bottom with increasing volume

Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)

Patents filed in China and expected to be filed in USA

Patents and the clinical trials include over 20 years of data

Targeted areas:

Autoimmune states such as rheumatoid arthritis and multiple sclerosis

As an adjunct to antibiotics in the treatment of infectious diseases

In cancer patients undergoing chemotherapy, radiation treatments or surgery

Patients with AIDS, in combination with retroviral drug therapy

In wound healing or herpes viral infections

Symbol is TNIB
News Link: http://finance.yahoo.com/q?s=tnib&ql=1

Please review the videos and articles related to immunotherapy, cancer treatments, and other related topics.

MENK Clinical Trials
MENK Articles
MENK Studies
LDN Clinical Trials
LDN Articles
LDN Studies

Company Overview
TNI BioTech Inc. is a biotech company combating fatal diseases through the activation and mobilization of the body’s immune system using our patented immunotherapy.

Our products and technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS and autoimmune diseases. We have been developing active and adaptive forms of immunotherapies.

Our proprietary technology, therapies and patents, will be used to treat a wide range of cancers. Our most advanced clinical programs involve immunotherapy that works by isolating a patient’s lymphocytes and then incubating them together with Methionine Enkephalin (MENK) in an enriching external incubation system. After incubation the patient’s lymphocytes are reinfused back into the patient where they combat and destroy tumor cells.

TNI BioTech Products

IRT-101 is an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells. This is accomplished by increasing the number of T cells and NK cells, NKT and Gammadelta T cells that destroy infective organisms and tumor cells while simultaneously inhibiting Treg cells.

IRT-102 is an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells and following an enriching external incubation are transfused back into the patient thereby providing the patient with a passive immunity containing large amounts of auto-amplified immune cells that combat cancer cells.

IRT- 103 is an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells. This is accomplished by activating the enkephalin receptor system resulting in increased number of T cells and NK cells that destroy infective organisms and tumor cells.

However, since any condition that results in an altered-immune response is a potential target for investigation. The Company intends to investigate the following valuable candidates:

Autoimmune states such as rheumatoid arthritis and multiple sclerosis.
As an adjuvant to vaccines in the protection from getting infectious diseases
In patients undergoing chemotherapy or radiation treatments in surgery
In wound healing, herpes and shingles in the elderly.
In clinical trials the evidence is significant that LDN/MENK stimulates the immune system and that it is effective in the treatment of some immune-suppressed diseases. The treatment modality has been demonstrated to be effective while avoiding certain deleterious effects on the body, as is often the case with traditional chemotherapy. The costs are reasonable, making this an attractive complement for a large number of cancer patients

Global Investment Media
310-353-6277

Investor Relations
Marlin Molinaro
Marmel Communications, LLC
702-434-8692

Website: http://www.tnibiotech.com/

TNI BioTech, Inc. Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)Marketwire(Tue 7:48AM EDT)
Dr. Ronald Herberman Joins TNI BioTech Inc. as Senior Vice President of Research and Development and Chief Medical OfficerMarketwire(Thu, Sep 6)
TNI BioTech, Inc. Acquires Portfolio of Exclusive Licenses to the Portfolio of Patents of Dr. Bernard BihariMarketwire(Tue, Aug 28)
TNI BioTech, Inc., in Partnership With GB Oncology and Imaging Group LTD., Signs Agreement With the Republic of MalawiMarketwire(Tue, Aug 7)
TNI BioTech, Inc. Announces Memorandum of Agreement With GB Oncology and Imaging Group LTDMarketwire(Tue, Jul 24)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

BMAP Expands: Bridging Borders in Legal Advocacy

Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...

Inovonics Duress Card Enhances Safety for K-12 and Beyond

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Avive Partners with Cambridge Fire for Lifesaving Training

Tapping into the Pulse: Avive & Cambridge Fire in Action No fooling around here—Avive Solutions is linking arms with the Cambridge Fire Department to put the city on a faster track to becoming a lifesaver haven. They're rolling out a free CPR and AED training right in the Smith Campus Center, Harvard Square. It's the kind of thing you love to see—getting the community...

NY Sheriffs' Court Battle: Immigration Policies Under Fire

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

FC2 Condom Educates NYC on Health and Wellness

Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...

G-STAR & Wu-Tang Clan Unleash Denim Fusion

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

MasterBrand's 2027 Kitchen Trends: Embrace Warmth

Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...

RxWellness Hits Inc. 5000—Four Straight Wins Impress

RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...

Perk's U.S. Expansion: A Bold Move in Spend Control

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...